Multiple immune cell populations and soluble mediators

The term Multiple immune cell populations and soluble mediators refers to the integrated network of the immune system rather than a single molecular target. This network includes various cell types, such as lymphocytes, myeloid cells, and granulocytes, alongside the signaling molecules they secrete, such as cytokines, chemokines, and interferons (Janeway et al., Immunobiology, 2001). In clinical pharmacology, this system is the focus of therapies aimed at modulating the overall immune environment to treat complex pathologies like malignancy or chronic inflammation (NIH, 2023). Because it involves numerous redundant and synergistic pathways, therapeutic intervention often requires targeting specific nodes within this system—such as PD-1 on T cells or TNF-alpha in the serum—to achieve a desired systemic effect (Binnewies et al., Nature Medicine, 2018). Consequently, while not a single target itself, it represents the functional landscape where immunotherapies and anti-inflammatory drugs exert their clinical impact (StatPearls, 2023). This designation is considered incorrect as a specific therapeutic target because it encompasses an entire biological system rather than a discrete, druggable molecule.

Other names

Immune systemImmune microenvironmentInflammatory milieuImmune landscapeCytokine and cellular network

Broad modulation of immune cell recruitment, activation, and signaling through the inhibition or stimulation of specific receptors and cytokines within the immune network.